Reuters logo
US approves Mylan's purchase of Strides unit, with conditions
September 26, 2013 / 10:24 PM / 4 years ago

US approves Mylan's purchase of Strides unit, with conditions

WASHINGTON, Sept 26 (Reuters) - Generic drugmaker Mylan Inc has won U.S. antitrust approval, with conditions, to buy Agila, a unit of India’s Strides Arcolab Ltd, the Federal Trade Commission said on Thursday.

The companies will have to divest 11 generic injectable drugs as a condition of approving the deal, the FTC said.

The deal was valued at $1.6 billion when it was announced in February.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below